English
简体中文
Total: £ 56.28
Published Date: 2024-04-10 | Pages: 83 | Tables: 176 | New Technology
The global Oral Antiviral Medicines for COVID-19 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Antiviral Medicines for COVID-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antiviral Medicines for COVID-19.
Report Scope
The Oral Antiviral Medicines for COVID-19 market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Antiviral Medicines for COVID-19 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Antiviral Medicines for COVID-19 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Merck
Shionogi
Simcere Pharmaceutical
Frontier Biotechnologies
Kexing Biopharm
Segment by Type
Lagevrio
Paxlovid
Azvudine
Segment by Application
Aldult
Elder
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Antiviral Medicines for COVID-19 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Antiviral Medicines for COVID-19 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Oral Antiviral Medicines for COVID-19 Market Overview
1.1 Product Overview and Scope of Oral Antiviral Medicines for COVID-19
1.2 Oral Antiviral Medicines for COVID-19 Segment by Type
1.2.1 Global Oral Antiviral Medicines for COVID-19 Market Value Comparison by Type (2024-2030)
1.2.2 Lagevrio
1.2.3 Paxlovid
1.2.4 Azvudine
1.3 Oral Antiviral Medicines for COVID-19 Segment by Application
1.3.1 Global Oral Antiviral Medicines for COVID-19 Market Value by Application: (2024-2030)
1.3.2 Aldult
1.3.3 Elder
1.4 Global Oral Antiviral Medicines for COVID-19 Market Size Estimates and Forecasts
1.4.1 Global Oral Antiviral Medicines for COVID-19 Revenue 2019-2030
1.4.2 Global Oral Antiviral Medicines for COVID-19 Sales 2019-2030
1.4.3 Global Oral Antiviral Medicines for COVID-19 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Antiviral Medicines for COVID-19 Market Competition by Manufacturers
2.1 Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Antiviral Medicines for COVID-19 Average Price by Manufacturers (2019-2024)
2.4 Global Oral Antiviral Medicines for COVID-19 Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Antiviral Medicines for COVID-19, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Antiviral Medicines for COVID-19, Product Type & Application
2.7 Oral Antiviral Medicines for COVID-19 Market Competitive Situation and Trends
2.7.1 Oral Antiviral Medicines for COVID-19 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Antiviral Medicines for COVID-19 Players Market Share by Revenue
2.7.3 Global Oral Antiviral Medicines for COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Antiviral Medicines for COVID-19 Retrospective Market Scenario by Region
3.1 Global Oral Antiviral Medicines for COVID-19 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Antiviral Medicines for COVID-19 Global Oral Antiviral Medicines for COVID-19 Sales by Region: 2019-2030
3.2.1 Global Oral Antiviral Medicines for COVID-19 Sales by Region: 2019-2024
3.2.2 Global Oral Antiviral Medicines for COVID-19 Sales by Region: 2025-2030
3.3 Global Oral Antiviral Medicines for COVID-19 Global Oral Antiviral Medicines for COVID-19 Revenue by Region: 2019-2030
3.3.1 Global Oral Antiviral Medicines for COVID-19 Revenue by Region: 2019-2024
3.3.2 Global Oral Antiviral Medicines for COVID-19 Revenue by Region: 2025-2030
3.4 North America Oral Antiviral Medicines for COVID-19 Market Facts & Figures by Country
3.4.1 North America Oral Antiviral Medicines for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Antiviral Medicines for COVID-19 Sales by Country (2019-2030)
3.4.3 North America Oral Antiviral Medicines for COVID-19 Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Antiviral Medicines for COVID-19 Market Facts & Figures by Country
3.5.1 Europe Oral Antiviral Medicines for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Antiviral Medicines for COVID-19 Sales by Country (2019-2030)
3.5.3 Europe Oral Antiviral Medicines for COVID-19 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Antiviral Medicines for COVID-19 Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Antiviral Medicines for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Antiviral Medicines for COVID-19 Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Antiviral Medicines for COVID-19 Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oral Antiviral Medicines for COVID-19 Market Facts & Figures by Country
3.7.1 Latin America Oral Antiviral Medicines for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Antiviral Medicines for COVID-19 Sales by Country (2019-2030)
3.7.3 Latin America Oral Antiviral Medicines for COVID-19 Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Antiviral Medicines for COVID-19 Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Antiviral Medicines for COVID-19 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Antiviral Medicines for COVID-19 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Antiviral Medicines for COVID-19 Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Antiviral Medicines for COVID-19 Sales by Type (2019-2030)
4.1.1 Global Oral Antiviral Medicines for COVID-19 Sales by Type (2019-2024)
4.1.2 Global Oral Antiviral Medicines for COVID-19 Sales by Type (2025-2030)
4.1.3 Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Type (2019-2030)
4.2 Global Oral Antiviral Medicines for COVID-19 Revenue by Type (2019-2030)
4.2.1 Global Oral Antiviral Medicines for COVID-19 Revenue by Type (2019-2024)
4.2.2 Global Oral Antiviral Medicines for COVID-19 Revenue by Type (2025-2030)
4.2.3 Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Type (2019-2030)
4.3 Global Oral Antiviral Medicines for COVID-19 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Antiviral Medicines for COVID-19 Sales by Application (2019-2030)
5.1.1 Global Oral Antiviral Medicines for COVID-19 Sales by Application (2019-2024)
5.1.2 Global Oral Antiviral Medicines for COVID-19 Sales by Application (2025-2030)
5.1.3 Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Application (2019-2030)
5.2 Global Oral Antiviral Medicines for COVID-19 Revenue by Application (2019-2030)
5.2.1 Global Oral Antiviral Medicines for COVID-19 Revenue by Application (2019-2024)
5.2.2 Global Oral Antiviral Medicines for COVID-19 Revenue by Application (2025-2030)
5.2.3 Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Application (2019-2030)
5.3 Global Oral Antiviral Medicines for COVID-19 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Oral Antiviral Medicines for COVID-19 Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Oral Antiviral Medicines for COVID-19 Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Shionogi
6.3.1 Shionogi Corporation Information
6.3.2 Shionogi Description and Business Overview
6.3.3 Shionogi Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shionogi Oral Antiviral Medicines for COVID-19 Product Portfolio
6.3.5 Shionogi Recent Developments/Updates
6.4 Simcere Pharmaceutical
6.4.1 Simcere Pharmaceutical Corporation Information
6.4.2 Simcere Pharmaceutical Description and Business Overview
6.4.3 Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Product Portfolio
6.4.5 Simcere Pharmaceutical Recent Developments/Updates
6.5 Frontier Biotechnologies
6.5.1 Frontier Biotechnologies Corporation Information
6.5.2 Frontier Biotechnologies Description and Business Overview
6.5.3 Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Product Portfolio
6.5.5 Frontier Biotechnologies Recent Developments/Updates
6.6 Kexing Biopharm
6.6.1 Kexing Biopharm Corporation Information
6.6.2 Kexing Biopharm Description and Business Overview
6.6.3 Kexing Biopharm Oral Antiviral Medicines for COVID-19 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kexing Biopharm Oral Antiviral Medicines for COVID-19 Product Portfolio
6.6.5 Kexing Biopharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Antiviral Medicines for COVID-19 Industry Chain Analysis
7.2 Oral Antiviral Medicines for COVID-19 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Antiviral Medicines for COVID-19 Production Mode & Process
7.4 Oral Antiviral Medicines for COVID-19 Sales and Marketing
7.4.1 Oral Antiviral Medicines for COVID-19 Sales Channels
7.4.2 Oral Antiviral Medicines for COVID-19 Distributors
7.5 Oral Antiviral Medicines for COVID-19 Customers
8 Oral Antiviral Medicines for COVID-19 Market Dynamics
8.1 Oral Antiviral Medicines for COVID-19 Industry Trends
8.2 Oral Antiviral Medicines for COVID-19 Market Drivers
8.3 Oral Antiviral Medicines for COVID-19 Market Challenges
8.4 Oral Antiviral Medicines for COVID-19 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Oral Antiviral Medicines for COVID-19 Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Antiviral Medicines for COVID-19 Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Antiviral Medicines for COVID-19 Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Antiviral Medicines for COVID-19 Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Antiviral Medicines for COVID-19 Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Antiviral Medicines for COVID-19 Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Antiviral Medicines for COVID-19 Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Antiviral Medicines for COVID-19, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Antiviral Medicines for COVID-19, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Antiviral Medicines for COVID-19, Product Type & Application
Table 12. Global Key Manufacturers of Oral Antiviral Medicines for COVID-19, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Antiviral Medicines for COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antiviral Medicines for COVID-19 as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Antiviral Medicines for COVID-19 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Antiviral Medicines for COVID-19 Sales by Region (2019-2024) & (Units)
Table 18. Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Region (2019-2024)
Table 19. Global Oral Antiviral Medicines for COVID-19 Sales by Region (2025-2030) & (Units)
Table 20. Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Region (2025-2030)
Table 21. Global Oral Antiviral Medicines for COVID-19 Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Antiviral Medicines for COVID-19 Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Antiviral Medicines for COVID-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Antiviral Medicines for COVID-19 Sales by Country (2019-2024) & (Units)
Table 27. North America Oral Antiviral Medicines for COVID-19 Sales by Country (2025-2030) & (Units)
Table 28. North America Oral Antiviral Medicines for COVID-19 Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Antiviral Medicines for COVID-19 Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Antiviral Medicines for COVID-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Antiviral Medicines for COVID-19 Sales by Country (2019-2024) & (Units)
Table 32. Europe Oral Antiviral Medicines for COVID-19 Sales by Country (2025-2030) & (Units)
Table 33. Europe Oral Antiviral Medicines for COVID-19 Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Antiviral Medicines for COVID-19 Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Antiviral Medicines for COVID-19 Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Antiviral Medicines for COVID-19 Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Oral Antiviral Medicines for COVID-19 Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Oral Antiviral Medicines for COVID-19 Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Antiviral Medicines for COVID-19 Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Antiviral Medicines for COVID-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Antiviral Medicines for COVID-19 Sales by Country (2019-2024) & (Units)
Table 42. Latin America Oral Antiviral Medicines for COVID-19 Sales by Country (2025-2030) & (Units)
Table 43. Latin America Oral Antiviral Medicines for COVID-19 Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Antiviral Medicines for COVID-19 Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Antiviral Medicines for COVID-19 Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Antiviral Medicines for COVID-19 Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa Oral Antiviral Medicines for COVID-19 Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa Oral Antiviral Medicines for COVID-19 Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Antiviral Medicines for COVID-19 Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Antiviral Medicines for COVID-19 Sales (Units) by Type (2019-2024)
Table 51. Global Oral Antiviral Medicines for COVID-19 Sales (Units) by Type (2025-2030)
Table 52. Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Type (2019-2024)
Table 53. Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Type (2025-2030)
Table 54. Global Oral Antiviral Medicines for COVID-19 Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Antiviral Medicines for COVID-19 Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Antiviral Medicines for COVID-19 Price (US$/Unit) by Type (2019-2024)
Table 59. Global Oral Antiviral Medicines for COVID-19 Price (US$/Unit) by Type (2025-2030)
Table 60. Global Oral Antiviral Medicines for COVID-19 Sales (Units) by Application (2019-2024)
Table 61. Global Oral Antiviral Medicines for COVID-19 Sales (Units) by Application (2025-2030)
Table 62. Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Application (2019-2024)
Table 63. Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Application (2025-2030)
Table 64. Global Oral Antiviral Medicines for COVID-19 Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Antiviral Medicines for COVID-19 Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Antiviral Medicines for COVID-19 Price (US$/Unit) by Application (2019-2024)
Table 69. Global Oral Antiviral Medicines for COVID-19 Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Oral Antiviral Medicines for COVID-19 Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck Oral Antiviral Medicines for COVID-19 Product
Table 79. Merck Recent Developments/Updates
Table 80. Shionogi Corporation Information
Table 81. Shionogi Description and Business Overview
Table 82. Shionogi Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Shionogi Oral Antiviral Medicines for COVID-19 Product
Table 84. Shionogi Recent Developments/Updates
Table 85. Simcere Pharmaceutical Corporation Information
Table 86. Simcere Pharmaceutical Description and Business Overview
Table 87. Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Product
Table 89. Simcere Pharmaceutical Recent Developments/Updates
Table 90. Frontier Biotechnologies Corporation Information
Table 91. Frontier Biotechnologies Description and Business Overview
Table 92. Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Product
Table 94. Frontier Biotechnologies Recent Developments/Updates
Table 95. Kexing Biopharm Corporation Information
Table 96. Kexing Biopharm Description and Business Overview
Table 97. Kexing Biopharm Oral Antiviral Medicines for COVID-19 Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Kexing Biopharm Oral Antiviral Medicines for COVID-19 Product
Table 99. Kexing Biopharm Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Oral Antiviral Medicines for COVID-19 Distributors List
Table 103. Oral Antiviral Medicines for COVID-19 Customers List
Table 104. Oral Antiviral Medicines for COVID-19 Market Trends
Table 105. Oral Antiviral Medicines for COVID-19 Market Drivers
Table 106. Oral Antiviral Medicines for COVID-19 Market Challenges
Table 107. Oral Antiviral Medicines for COVID-19 Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Antiviral Medicines for COVID-19
Figure 2. Global Oral Antiviral Medicines for COVID-19 Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Antiviral Medicines for COVID-19 Market Share by Type in 2023 & 2030
Figure 4. Lagevrio Product Picture
Figure 5. Paxlovid Product Picture
Figure 6. Azvudine Product Picture
Figure 7. Global Oral Antiviral Medicines for COVID-19 Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Oral Antiviral Medicines for COVID-19 Market Share by Application in 2023 & 2030
Figure 9. Aldult
Figure 10. Elder
Figure 11. Global Oral Antiviral Medicines for COVID-19 Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Oral Antiviral Medicines for COVID-19 Market Size (2019-2030) & (US$ Million)
Figure 13. Global Oral Antiviral Medicines for COVID-19 Sales (2019-2030) & (Units)
Figure 14. Global Oral Antiviral Medicines for COVID-19 Average Price (US$/Unit) & (2019-2030)
Figure 15. Oral Antiviral Medicines for COVID-19 Report Years Considered
Figure 16. Oral Antiviral Medicines for COVID-19 Sales Share by Manufacturers in 2023
Figure 17. Global Oral Antiviral Medicines for COVID-19 Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Oral Antiviral Medicines for COVID-19 Players: Market Share by Revenue in 2023
Figure 19. Oral Antiviral Medicines for COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Oral Antiviral Medicines for COVID-19 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Oral Antiviral Medicines for COVID-19 Sales Market Share by Country (2019-2030)
Figure 22. North America Oral Antiviral Medicines for COVID-19 Revenue Market Share by Country (2019-2030)
Figure 23. United States Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Oral Antiviral Medicines for COVID-19 Sales Market Share by Country (2019-2030)
Figure 26. Europe Oral Antiviral Medicines for COVID-19 Revenue Market Share by Country (2019-2030)
Figure 27. Germany Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Oral Antiviral Medicines for COVID-19 Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Oral Antiviral Medicines for COVID-19 Revenue Market Share by Region (2019-2030)
Figure 34. China Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Oral Antiviral Medicines for COVID-19 Sales Market Share by Country (2019-2030)
Figure 44. Latin America Oral Antiviral Medicines for COVID-19 Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Oral Antiviral Medicines for COVID-19 Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Oral Antiviral Medicines for COVID-19 Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Oral Antiviral Medicines for COVID-19 Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Oral Antiviral Medicines for COVID-19 by Type (2019-2030)
Figure 54. Global Revenue Market Share of Oral Antiviral Medicines for COVID-19 by Type (2019-2030)
Figure 55. Global Oral Antiviral Medicines for COVID-19 Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Oral Antiviral Medicines for COVID-19 by Application (2019-2030)
Figure 57. Global Revenue Market Share of Oral Antiviral Medicines for COVID-19 by Application (2019-2030)
Figure 58. Global Oral Antiviral Medicines for COVID-19 Price (US$/Unit) by Application (2019-2030)
Figure 59. Oral Antiviral Medicines for COVID-19 Value Chain
Figure 60. Oral Antiviral Medicines for COVID-19 Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
